Oversea Chinese Banking Corp LTD Teva Pharmaceutical Industries LTD Transaction History

Oversea Chinese Banking Corp LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 29, 2024	BUY	$7.48 - $10.7 $79,669 - $113,965	10,651 New	10,651 $108,000
Q1 2023 Sep 15, 2023	SELL	$8.36 - $11.37 $572,626 - $778,799	-68,496 Reduced 86.54%	10,651 $94,000
Q4 2022 Sep 15, 2023	BUY	$7.95 - $9.48 $544,543 - $649,342	68,496 Added 643.09%	79,147 $721,000
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $84,675 - $100,971	10,651 New	10,651 $0

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.